Speichel, Kapillarblut/-plasma, Urin – welche Matrix für welchen Zweck?, Lierheimer S, Neumann J, Böttcher M, Toxichem Krimtech, 93(1), 86-92, 2026
Überlegungen zur Festlegung eines Erwartungsbereichs für die EtG/EtS-Ratio in Urinproben, Neumann J, Böttcher M, Toxichem Krimtech, 92(3), 204-212, 2025
Naturalistic comparison of clomethiazole and diazepam treatment in alcohol withdrawal: effects on oxidative stress, inflammatory cytokines and hepatic biomarkers, Strischewski D, Kalmar A, Guest PC, Dobrowolny H, Meyer-Lotz G, Schiffner CJ, Jordan W, Müller UJ, Borucki K, Böttcher M, Relja B, Steiner J, Eur Arch Psych Clin Neurosc, published online 2024, https://doi.org/10.1007/s00406-024-01835-7
Levomethadone therapeutic drug monitoring to aid opioid withdrawal therapy: a short communication, Pfeifer P, Hildebrand K, Angelow A, Havemann-Reinecke U, Böttcher M, Hiemke C, Prentice T, Roll SC, Ther Drug Monit, Vol 45, No 6, 772-776, 2023
Towards adherence monitoring using breath or oral fluid as a matrix in a methadone maintenance treatment program for patients with a chronic heroin use disorder: Issues and interpretation of the results, de Jong LAA, Kloost T, Olyslager EJH, Böttcher M, Wieferink JA, Vossenberg P, Belgers M, Beurmanjer H, de Haan HA, JAT 47, No. 9, 842-849, 2023
A rapid and convenient sample preparation method for the analysis of cannabinoids in oral fluid samples, Reinstadler V, Huber S, Lierheimer S, Boettcher M, Rüscher P, Tanzer M, Jenny K, Zoll A, Gruber W, Oberacher H, Biomedical Chromatography, e5651, 2023. doi.org/10.1002/bmc.5651
Microneedle patch for painless intradermal collection of interstitial fluid enabling multianalyte measurement of small molecules, SARS-CoV-2 antibodies, and protein profiling, Ribet F, Bendes A, Fredolini C, Dobielewski M, Böttcher M, Beck O, Schwenk JM, Stemme G, Roxhed N, Advanced Healthcare Materials 12, 13, 2023. doi.org/10.1002/adhm.202202564
Using naltrexone to validate a human laboratory test system to screen new medications for alcoholism (TESMA)- a randomized clinical trial, Spreer M, Grählert X, Klut IM, Al Hamdan F, Sommer WH, Plawecki MH, O´Connor S, Böttcher M, Sauer C, Smolka MN, Zimmermann US, Translational Psychiatry 13:113, 2023
Zur Präanalytik der PEth Bestimmung, Neumann J, Böttcher M, Z. f. Verkehrssicherheit 68, Nr. 5, 377-382, 2022
Periportal steatosis in mice affects distinct parameters of pericentral drug metabolism, Albary M, Höpfl S, Ehteshamzad N, König M, Böttcher M, Neumann J, Lupp A, Dirsch O, Radde N, Christ B, Christ M, Schwen LO, Laue H, Klopfleisch R, Dahmen U, Nature Scientific Reports 12:21825, 2022
Feasibility of using breath sampling of non-volatiles to estimate the prevalence of illicit drug use among nightlife attendees, Feltmann K, Elgan T.H., Böttcher M, Lierheimer S, Hermansson S, Beck O, Gripenberg J, Nature Scientific Reports 12:20283, 2022
Comparative LCMS/MS drug analysis of paired urine, oral fluid and capillary blood samples in addiction therapy, Huppertz B, Böttcher M, Lierheimer S, Gottwald P, Bleicher S, Schäfer M, Ann Clin Lab Res Vol. 10 No. 6: 416, 2022
Buprenorphine-cannabis interaction in patients undergoing opioid maintenance therapy, Vierke C, Marxen B, Boettcher M, Hiemke C, Havemann-Reinecke U, Eur Arch Psychiatry Clin Neurosci., 271: 847-856, 2021
Magic Mushroom or Toad slime? – Distinguishing between bufotenine and psilocin with the Toxtyper, Stemmerich K, Schulz K, Peschel A, Böttcher M, Sewell A, Arndt T, TIAFT Bulletin, 51(4), 4-12, 2021
Phosphatidylethanol, ethyl glucuronide and ethanol in blood as complementary biomarkers for alcohol consumption, Neumann J, Beck O, Böttcher M, J Mass Spectrometry Advances Clinical Lab 22 p 3-7, 2021
Hydromorphone and codeine concentrations in oral fluid specimens from patients receiving substitution therapy with Substitol (morphine sulfate), Lierheimer S, Beck O, Keller T, Monticelli FC, Böttcher M, Drug Test Anal. 13(10), 1743-1748, 2021
Ethyl glucuronide and ethanol concentrations in femoral blood, urine and vitreous humor from 117 autopsy cases, Neumann J, Keller T, Monticelli F, Beck O, Böttcher M, Forensic Sci Int 318, 1-7, 2021
Weder Zauberpilz noch Krötenschleim – Zur Differenzierung von Bufotenin und Psilocin mit dem Toxtyper, Stemmerich K, Schulz K, Peschel A, Böttcher M, Arndt T, Toxichem Krimtech, 88(1), 51-62, 2021
Der CEDIA Probenkontroll-Assay – Einsatzmöglichkeiten und Grenzen eines Probenintegritätstests, Franz S, Skopp G, Böttcher M, Musshoff F, Zeitschrift für Verkehrssicherheit 66, 313-316, 2020
Sensitive determination of ethyl glucuronide in serum and whole blood: detection time after alcohol exposure compared with urine, Neumann J, Beck O, Helander A, Dahmen N, Böttcher M, J Lab Med 44(4): 211-219, 2020
Challenges of LC-MS/MS Ethyl Glucuronide analysis in abstinence monitoring of liver transplant patients, Heinemann ML, Elsing L, Kaiser T, Boettcher M, Herber A, Seehofer D, Berg T, Ceglarek U, Clin Chem Lab Med. 58(8), 1265-1270, 2020
Performance of PEth compared with other alcohol biomarkers in subjects presenting for occupational and pre-employment medical examination, Neumann J., Beck O, Helander A, Böttcher M, Alcohol and Alcoholism 55(4), 401-408, 2020
Prolonged ketamine and norketamine excretion profiles in urine after chronic use, de Jong LAA, Qurishi R, Stams M, Böttcher M, de Jong CAJ, J Clin Psychopharmacol, 40 (3), 300-304, 2020.
Buprenorphine-cannabis interaction in patients undergoing opioid maintenance therapy, Vierke C, Marxen B, Boettcher M, Hiemke C, Havemann-Reinecke U, Eur Arch Psychiatry Clin Neurosci., published online 01/2020
Compliance testing of patients in ADHD treatment with lisdexamphetamine (Elvanse) using oral fluid as specimen, Böttcher M, Kühne D, Beck O, Clinical Mass Spectrometry 14, 99-105, 2019
Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology guideline: development and validation of Dried Blood Spot-based methods for Therapeutic Drug Monitoring, Capiau S, Veenhof H, Koster RA, Bergqvist Y, Boettcher M, Halmingh O, Keevil BG, Koch BCP, Linden R, Pistos C, Stolk LM, Touw DJ, Stove CP, Alfenaar J-WC, Ther Drug Monit, 41: 409-430, 2019;
Elimination characteristics of the alcohol biomarker phosphatidylethanol (PEth) in blood during alcohol detoxification, Helander A, Böttcher M, Dahmen N, Beck O, Alcohol and Alcoholism 54(3), 251-257, 2019
Detection of heroin intake in patients in substitution treatment using oral fluid as specimen for drug testing, Böttcher M, Lierheimer S, Peschel A, Beck O, Drug and Alcohol Dependence 198, 136-139, 2019
Evaluation of an on-site test device for the heroin metabolite 6-acetylmorphine in urine, Picht F, Beck O, Böttcher M, Drug Test Anal. 11(3), 536-540, 2019
Creatinine excretion in consecutive urine samples after controlled ingestion of water, Franz S, Skopp G, Böttcher M, Musshoff F, Drug Test Anal. 11(3), 435-440, 2019
A validated workflow for drug detection in oral fluid by non-targeted liquid chromatography-tandem mass spectrometry, Reinstadler V, Lierheimer S, Böttcher M, Oberacher H, Analytical and Bioanalytical Chemistry 411: 867-876, 2019
Aktuelle Nachweismethoden von Substanzkonsum, Böttcher M, Waizmann M, Ärzteblatt Sachsen, 343-345, 08/2018
Oral fluid – a suitable specimen for compliance testing in psychopharmacotherapy and substitution therapy, Böttcher M, Beck O, The IATDMCT Compass Vol 17,1, 2018
Potential of oral fluid as a clinical specimen for compliance monitoring of psychopharmacotherapy, Neumann J, Beck O, Dahmen N, Böttcher M, Ther Drug Monit, 40: 245-251, 2018
Salivary neuropeptides, stress, and periodontitis, Haririan H, Andrukhov O, Böttcher M, Pablik E, Wimmer G, Moritz A, Rausch-Fan X, J Periodontol 89, 9-18, 2018.
Sevoflurane metabolite cross-react in the ethyl glucuronide DRI immunoassay, Böttcher M, Kühne D, Beck O, Drug Test Anal. 10(2), 379-380, 2018
Induction of autophagy reduces ischemia/reperfusion injury in steatotic rat livers, Kan C, Liu A, Fang H, Dirsch O, Dahmen U, Boettcher M, J Surg Res., 216, 207-218, 2017
Integration of clinical examination, self-report, and hair ethyl glucuronide analysis for evaluation of patients with alcoholic liver disease prior to liver transplantation, Beckmann M, Paslaki G, Böttcher M, Helander A, Erim Y, Progress in Transplantation, 26 (1), 40-46, 2016
Feasibility and acceptability of an alcohol addiction therapy integrated in a transplant center for patients awaiting liver transplantation, Erim Y, Böttcher M, Schieber K, Lindner M, Klein C, Paul A, Beckebaum S, Mayr A, Helander A, Alcohol Alcohol. 51 (1), 40-46, 2016
Stabilitätsuntersuchungen zu Ethylglucuronid bei bakteriell kontaminierten Urinen , Bartling C, Böttcher M, Toxichem Krimtech; 82 (Special Issue): 199-201, 2015.
Evaluation of a commercial LC-MS/MS assay for the quantification of ethyl glucuronide in urine for alcohol intake monitoring, Becker S, Brauer R, Böttcher M, Thiery J, Ceglarek U, J Lab Med 39(3): 159-163, 2015
Drogen- und Medikamententestung im Speichel, Böttcher M, Trillium Diagnostik 12(2), 82-83, 2014
Salivary and serum chromogranin A and alpha-amylase in periodontal health and disease, Haririan H, Bertl K, Laky M, Rausch W-D, Böttcher M, Matejka M, Andrukhov O, Rausch-Fan X, J Periodontology, 2012
An enzymatic method to determine y-hydroxybutyric acid in serum and urine, Hasan L, Jermann T M, Weber J, Abrahamsson L, Sciotti M-A, Böttcher M, Jöchle W, Gygax D, Scholer A, Ther Drug Monit 33, No. 6, 757-765, 2011
Study on the sampling of methadone from exhaled breath, Beck O, Sandqvist S, Böttcher M, Eriksen P, Franck J, Palmskog G, JAT 35, No. 5, 257-263, 2011
Quantification of 11-nor-9-carboxy-delta9-tetrahydrocannabinol (CTHC) Equivalents in Urine using instrumentally read Gold-labeled Lateral Flow Immunoassays (IRGLFIA) in Order to Predict THC in Serum >= 1 ng/mL, Haisser J, Tiemann B, Protzek C, Boettcher M, Aderjan R, Toxichem Krimtech 78 (Special Issue), p. 332-336, 2011
